Press release
Neuronfab Launches Operations, Ushering in a New Era of Biotechnology Innovation
Cologne, January 2025 – After months in stealth mode, Neuronfab proudly announces the official start of operations in January 2025, marking a significant milestone in neuroscience-based biotechnology. The name ‘Neuronfab’ reflects our mission to craft advanced neural solutions that empower researchers and innovators worldwide. From creating cutting-edge human brain organoids to replacing outdated animal models, Neuronfab is dedicated to driving meaningful progress in neuroscience.
Brain. Health. Live.
At Neuronfab, our mission is simple yet transformative: to improve the quality and longevity of human life while replacing animal testing. Our neuroscience-driven solutions are designed to bridge the gap between scientific discovery and real-world applications, offering unparalleled precision and reliability for disease modeling, drug testing, and beyond.
The Human Brain is Unique
The human brain’s remarkable complexity, cell diversity, and architecture set it apart from animal brains. Relying on animal models to study the biology of the human brain often yields incomplete or misleading results. “There’s no reason to rely on outdated models when advanced tools like human brain organoids can provide superior relevance and accuracy,” said Dr. Elke Gabriel, Chief Science Officer.
Billions are Wasted on the Wrong Models
Pharmaceutical companies lose billions every year on drug development and disease modeling based on ineffective animal systems. With failure rates as high as 90%, the industry faces significant challenges in translating research into effective treatments. Neuronfab’s human-relevant models address this gap, enabling breakthroughs that are faster, more accurate, and less wasteful.
Highlights of Neuronfab’s Launch
-
State-of-the-Art Offerings: Products include human brain organoids and retina models for research, drug development, and disease modeling.
-
Proprietary Technology: Scalable and innovative methods ensure high-quality, reproducible solutions.
-
Ethical and Effective Alternatives: Focused on replacing animal testing with human-relevant, ethically developed models.
-
Future Vision: A commitment to expanding the portfolio and fostering collaborations with global researchers.
A Commitment to Progress
“Neuronfab represents a new era in neuroscience,” said Valeria Küpper, CEO. “By combining cutting-edge science with a mission to replace ineffective models, we’re not only advancing human health but also addressing a longstanding gap in research and drug development.”
About Neuronfab
Neuronfab is a biotechnology startup dedicated to revolutionizing neuroscience research and applications. With solutions such as human brain organoids, retina models, and contract research services, we are building a platform for innovation that prioritizes efficiency, scalability, and ethical practices. Our goal is to replace outdated methods with human-specific, reliable models that empower researchers and innovators worldwide.
For media inquiries, please contact:
contact@neuronfab.com